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Behavioural aspects of a modified crosstalk between basal 
ganglia and limbic system in Parkinson’s disease
Dysfunctions in dopaminergic neurotransmission lead to motor symptoms and cognitive 
impairments associated with behavioural disturbances. Parkinson’s disease is a neurodegenera-
tive disorder which is primarily characterized by an abnormal basal ganglia activity. Recently, 
increased attention has been directed towards the hippocampus in the development of 
non-motor symptoms. Given the temporal progression of the disease, dopaminergic deple-
tion firstly affects the dorsal striatum leaving the ventral striatum relatively intact. However, 
it is possible that the structure and function of the hippocampus shows alterations even in 
early stages of Parkinson’s disease. Subtle cognitive impairments occur in the earliest stages, 
and therefore Parkinson’s disease could provide a unique model to investigate the effect 
of replacement therapies on a neural network with different baseline dopaminergic levels. 
Strong evidence suggests that dopaminergic medications improve the motor symptoms, 
but these medications might have disadvantageous effects on cognitive functions. In this 
review, we examine the role of dopaminergic changes across several cognitive and behav-
ioural impairments observed in Parkinson’s disease, with a special reference to hippocampal 
dysfunctions.
(Neuropsychopharmacol Hung 2016; 18(2): 087–092)
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The role of dopaminergic 
neuroTransmission in The hippocampus
According to traditional trends in the study of hu-
man memory, the hippocampus contains the most 
important and complex neural network. Memory is 
essential to adaptive behaviour (Euston et al., 2012). 
To accommodate to extrinsic environmental changes, 
the organism has to modify stimulus-response dimen-
sions in order to achieve the most flexible behav-
iour. Neuroplasticity plays a pivotal role in learning, 
i.e. in the formation and consolidation of memory. 
The hippocampus is considered as a fundamental 
example to functional neuroplasticity. It can be char-
acterised by LTP and long-term depression, which are 
considered as the cellular substrate of learning and 
memory (Bartish et al., 2015). 
Animal experiments demonstrated the dopamin-
ergic modulation of LTP. Electrophysiological studies 
on rat hippocampal slices provided evidence that D1/
D5 agonists enhanced the early phase of LTP in the 
CA1 hippocampal subregion. According to these re-
sults, during tetanic stimulation dopamine enhanced 
the postsynaptic depolarisation, which is pivotal for 
LTP induction. The requirement of tetanic stimula-
tion has computational importance in reinforcement 
learning (Otmakova et al., 1996).
Hamilton et al. (2010) reported similar findings: 
the induction of high frequency trains of D1 receptors 
in dentate granule cells activated dendritic voltage-
dependent calcium channels, which is another es-
sential physiological activator of dopamine-induced 
LTP. These experimental models provided evidence 
that high-frequency dopaminergic activity in the hip-
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pocampus strengthened the synapses which might 
facilitate reward associated spatial memory formation. 
The interaction between dopamine firing patterns 
and information flow provides an insight how the 
behaviour can be most effectively guided towards the 
goal to obtain a reward (Grace et al., 2007; Schomaker 
et al., 2015).
Behavioural studies exploring reward-motivated 
learning in healthy human subjects highlighted the 
importance of motivational salience. Learning can be 
inspired by expecting a provisional re-compensation 
before the knowledge is perceived. Neuroimaging 
studies using fMRI paradigms explored the antici-
patory mechanisms of reward motivated learning. 
By using a monetary incentive task, Adcock et al. 
(2006) found that cues predicting highly-rewarded 
and later remembered scenes activated the mesolim-
bic circuit (dopaminergic neurons in the ventral 
tegmental area, NAc and hippocampus). A positive 
correlation exists between hippocampal and ventral 
tegmental area activation, which is associated with 
long-term memory formation (Adcock et al., 2006).
The relationship behind these behavioural phe-
nomena could be explained by functional anatomical 
connections between the prefrontal cortex, hippo-
campus, basal ganglia, and midbrain (ventral tegmen-
tal area) dopaminergic systems (Calabresi et al., 2013).
dopamine in reward learning  
and novelTy seeKing behaviour
Based on electrophysiological studies it is proposed 
that the mesencephalic dopaminergic system can be 
divided into two functional components. The first is 
a slow, tonic release of dopamine, driven by an intrin-
sic pacemaker that maintains the low tonic concen-
tration. The second is a rapid, brief, high-amplitude 
phasic release of dopamine that is driven by behav-
iorally relevant burst firing of dopaminergic neurons. 
The phasic activity is dependent on afferent inputs and 
represents a functionally relevant signal to indicate 
reward and modulate goal-directed behaviour. Phasic 
changes in the bursting of dopaminergic neurons oc-
cur in response to primary or conditioned rewarding 
stimuli and have been proposed to mediate a predic-
tion error for anticipated rewards (Grace et al., 2007).
The mesencephalic dopaminergic system is in-
terconnected with limbic structures (including the 
hippocampus, and NAc) and the PFC via two differ-
ently directed anatomical links (upward- and down-
ward arc). In this model the NAc plays a pivotal role 
by integrating the incoming information under the 
modulatory influence of the dopamine system. NAc 
inputs coming from the limbic system and PFC are 
differentially regulated by dopaminergic receptor 
subtypes and dopaminergic firing pattern. 
Activation of D1 receptors by the high-amplitude 
phasic dopamine enhances the activity of the down-
ward arc which consists of glutamatergic projections 
from the hippocampus (subiculum) to the nucleus 
accumbens, followed by an inhibitory connection 
to the ventral pallidum, which releases tonic break 
on the midbrain dopaminergic neurons. This finally 
results in dopamine release from midbrain dopamin-
ergic neurons (Sesack et al., 2010).  
Computational models provided evidence that 
when the environmental contingencies are rewarding, 
the dopaminergic neurons fire in a phasic pattern. 
This pattern via D1-receptor activation enhances the 
downward arc and maintains the current behaviour to 
maintain the favourable outcome. A hyperdopamin-
ergic state (a’side effect’ of dopamine agonists) in the 
hippocampus – VTA loop would reciprocally potenti-
ate the subsequent responses, leading to impulsive-
compulsive behaviour (Calabresi et al., 2013). 
This circuit is also in charge to balance novelty 
gated information storage. The hippocampus is criti-
cal for providing the main novelty signal input to VTA. 
In turn the VTA releases dopamine that is necessary 
to stabilise and maintain LTP in the hippocampus 
(Wittman et al., 2007).
The upward arc consists of a connection from PFC 
to NAc. Tonic dopaminergic signalling inactivates 
the prefrontal inputs via D2 receptors, thus enabling 
the PFC to modulate the behaviour in compelling 
situations. Behavioural models shows that when the 
outcome is unfavourable (resulting in punishment), 
dopaminergic neurons show a tonic firing pattern 
that inhibits D2 receptors, resulting in PFC activa-
tion guiding the shift towards a desirable manner 
(Calabresi et al., 2013).
It is worthy to highlight the regional contribution 
of PFC in controlling different aspects of executive 
functions, thus directing towards a goal-directed 
behaviour. Summarising several modelling tech-
niques, Szczepanski et al. (2014) assumed that the 
lateral PFC is critical for selection and manipulation, 
the medial PFC is responsible for updating, and the 
role of the orbitofrontal cortex is to assign the social 
and emotional meaning to goal-directed behaviour.
The clinical data assessing unmedicated PD pa-
tients on reward-learning tasks are in accordance 
with the above mention approaches. Results of a lon-
gitudinal analysis on newly diagnosed-PD patients 
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revealed that the unmedicated status correlated with 
better punishment learning (no tonic dopamine to 
inactivate the PFC, so they are able to adjust), lower 
novelty seeking, and impaired performance on reward 
learning (hypodopaminergic state in VTA-hippocam-
pal loop). Retesting these patients after the initiation 
of dopaminergic therapy, the results were inversed: 
the deficits observed in reward learning and novelty 
seeking were remediated, but the punishment learn-
ing was disrupted (Bódi et al., 2009).
The distinct effect of dopaminergic medication 
on outcome-based learning can be proved as well 
by comparing PD patients ON and OFF medication. 
PD patients ON medication were better at learning 
from negative outcome compared to PD patients in 
OFF status. The OFF status was related to the avoid-
ance of a previously punishing stimulus (‘NoGo’ bias), 
whereas the ON condition was characterized by 
a higher ‘Go’ tendency to choose a previously reward-
ing stimulus (Frank et al., 2004).
dopaminergic mechanisms of TasK-
swiTching in The sTriaTum
Learning to reverse the responses to a formerly clas-
sified stimulus is a cognitive skill that enables to 
accommodate to current circumstances.
Reversal learning can be assessed using probabi-
listic reversal tasks. The first step is, called the acqui-
sition phase, when the subject learns to classify the 
stimuli by several trial-error reinforcements. In the 
next step the subject should comprehend that the 
previously learned stimulus is now associated with 
the opposite response – the participant learns to re-
verse the choice (Levy-Gigi et al., 2011). 
The intact ventral striatum plays a central role 
in task-switching. This function is affected in PD 
patients, and the dopaminergic replacement therapy 
has a discrepant effect on dopaminergic pathways. 
In early PD, dopamine depletion affects the dorsal 
striatum, whereas the ventral striatum is relatively 
intact. Thus, the medication necessary to remedy 
depleted dopamine levels in the dorsal striatum may 
‘over-dose’ dopamine levels in the relatively intact 
ventral striatum (MacDonald et al., 2011). Assessing 
the performance of patients ON and OFF dopamin-
ergic medication, patients ON medication exhibited 
impaired reversal shifting relative to patients OFF 
medication (Cools et al., 2006).
A functional imaging study in mild PD patients 
has strengthened this ‘over-dose’ hypothesis by con-
firming that the use of dopaminergic drugs modu-
lates the ventral striatum (NAc), but not the dorsal 
striatum during the performance of a probabilistic 
reversal shifting task (Cools et al., 2007).
Another group of investigators found similar 
impairments of reversal learning in PD patients on 
dopaminergic medication (Moustafa et al., 2014). 
They speculated that the learning process, more ex-
actly the reversal phase, is affected. According to this 
hypothesis, in the beginning of the reversal phase, 
the subject receives negative feedback, and because 
of an increase in tonic dopamine function in the PFC, 
the subject shifts attention to another cue instead of 
learning to reverse the responses.
basal ganglia and hippocampus  
in sequence learning
In learning and memory, the MTL (including the 
hippocampus) and the basal ganglia have dissoci-
able roles. The MTL is responsible for the establish-
ment of complex associations and integration among 
multiple stimulus dimensions (episodic memory) 
and it is important in situations when the stimuli are 
presented in a novel context. The basal ganglia sup-
port feedback-based learning of stimulus–response 
associations (procedural or habit learning) (Nagy et 
al., 2007; Shohamy et al., 2009; Dickerson et al., 2015).
Sequence learning, as assessed by the “chaining” 
task, allows a special insight to evaluate the MTL 
and BG functions at the same time within the same 
paradigm. In the “chaining” task, the task is to navi-
gate an animated character – “Kilroy” – through sev-
eral rooms. The final reward is provided when the 
animated character leaves the full chain of rooms. 
In each room, participants must learn the colour 
of the open door via a trial-error learning process. 
In the probe phase of the task, subjects had to prove 
that they learned the correct stimuli in the requested 
sequential manner. For the right choice, they had 
to use the context of stimulus-response association 
(Nagy et al., 2007).
By comparing the results from the “chaining” task 
between never-medicated PD patients (basal ganglia 
dysfunction) and a group of patients with amnes-
tic mild cognitive impairment (MTL dysfunction), 
a behavioural dissociation was found. Never-med-
icated PD patients had a good performance during 
the probe phase (preserved contextual learning), but 
showed impairments in the training phase of the 
chaining task (dysfunctional sequential learning). 
aMCI patients completed the task in an opposite man-
ner: they showed intact learning during the sequence 
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training, but diminished scores on probe phase (dys-
functional context learning) (Nagy et al., 2007).
The distinct roles of basal ganglia and hippocam-
pus in reversal-learning could be assessed using prob-
abilistic reversal classifications tasks. In probabilistic 
learning, a cue that was initially associated with one 
outcome 80% of the time will now be associated with 
another outcome 80% of the time. Reversal involves 
a successful change of stimulus-response contingency 
(Shohamy et al., 2009).
Patients with selective hippocampal damage (due 
to hypoxic brain injury) vs. subjects with basal ganglia 
dysfunctions (due to Parkinson’s disease) performed 
differently on this task. Both groups were intact at 
initial learning (guessing correctly the association 
between a visual cue and the corresponding category) 
but differed in their reversing features.
Amnestic patients failed to reverse the responses – 
they tended to perseverate, that is, they used the same 
cue-response association which was learned before. 
Interestingly, these patients also displayed mild im-
pairment in neuropsychological tests assessing the 
frontal functions. These findings suggest that the 
pathological background resulting in impairment in 
reversal learning might involve the prefrontal cortex 
as well (Shohamy et al., 2009).
Instead of reversing the response, PD patients 
learned and used a new cue-outcome association. 
This finding is consistent with previous results (Nagy 
et al., 2007) and also suggests that PD patients are 
impaired at learning tasks involving the integra-
tion of information through multiple cues and trials 
(Shohamy et al., 2009).
inTraTemporal choice in basal ganglia 
and hippocampus
The timing of the feedback following the response is 
another critical point in reward-oriented learning. 
An optimal learning mechanism should balance be-
tween the timing and the subjective magnitude of the 
reward. These assumptions raise an important ques-
tion: what pattern is applicable in PD if the feedback 
is delivered later?
Fourde et al. (2011) proposed a dynamic pattern 
which involves the hippocampus and the striatum. 
Patients with a disrupted nigrostriatal system (due to 
Parkinson’s disease) were impaired at learning from 
immediate feedback in a reinforcement learning 
task, but not when a delayed feedback was provided. 
The role of unaffected striatum in immediate response 
was proved in healthy individuals by functional MRI. 
They demonstrated a greater BOLD response in stria-
tum when the feedback was immediate, and in the 
hippocampus when the feedback was delayed. 
Another critical point in goal-oriented learning is 
the temporal delivery (arrival) of the reward. Increas-
ing attention has been paid to the phenomenon that 
dopaminergic medications applied for the treatment 
of PD contribute to development of behavioural ad-
dictions, clinically defined as impulsive-compulsive 
behaviour (Weintraub et al, 2010).
The classification of ICBs shows a great variety 
of clinical manifestations, including pathological 
gambling, compulsive shopping, compulsive sexual 
behaviour, and binge eating. Approximately 13.6% 
of Parkinson disease patients exhibit ICBs (Voon et 
al., 2011). An impulsive choice is characterised by 
a preference for immediately available rewards, even 
when it is smaller than delayed rewards. The tendency 
to prefer sooner, smaller but immediate rewards over 
those that are larger, but temporarily more distant can 
be quantified with delay discounting tasks (Housden 
et al., 2010; Napier et al., 2015). 
Two possible theories are suggested regarding 
the development of impulsive-compulsive behaviour. 
The first assumption postulates that ICB in PD reflects 
the ‘overvaluation’ of rewards due to the ‘overdosing 
effect’ in the relatively intact ventral striatum. A more 
accurate explanation is that dopamine in the ventral 
striatum mediates the incentive salience for the con-
ditioned stimuli, which elicits phasic dopamine firing.
The second theory describes another mechanism 
– the delay discounting – which might contribute 
to the appearance of impulsive-compulsive behav-
iour (Houseden at al., 2010). Comparing the effect 
of incentive salience (reinforced reward) and delay 
discounting in the development of ICB in PD patients, 
the ‘overestimation’ hypothesis seems to be incor-
rect. PD patients with ICB exhibited similar scores as 
the healthy control group on a reward learning task. 
However these scores were higher than the scores 
of PD patients without ICB, which contradicts the 
‘overestimation’ theory (Housden et al., 2010). 
A study conducted by Voon et al. (2010) found 
a greater impulsive choice in PD patients with medica-
tion-related ICBs. By implementing a feedback-based 
intratemporal choice task, they demonstrated that the 
PD patients with ICB on dopaminergic medication 
associated an increased impulsive choice compared 
with PD patients without ICB (Voon et al., 2010).
There is also a genetic association that may be 
uniquely associated with delay discounting in PD. 
It has been identified that SNCA gene duplication 
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carriers with PD exhibited increased impulsivity 
indicated by elevated delay discounting for reward 
(Szamosi et al., 2013).
Evidence from animal models demonstrated that 
the hippocampus has an important role to decide be-
tween an immediate-smaller or delayed-larger reward. 
Hippocampus lesioned rats tend to prefer immediate 
smaller rewards over delayed larger reward (Cheung 
et al., 2005; McHugh et al., 2008). These findings 
suggest that the hippocampal system is necessary 
for tolerating the delayed behavioural choice (Bett 
et al., 2010).
conclusion
Our review summarised several behavioural dys-
functions resulting from an impaired dopaminer-
gic neurotransmission in the extended basal gan-
glia – hippocampal system. We also described the 
pathophysiological background of some cognitive 
symptoms. PD was considered as a model of altered 
dopaminergic transmission, assuming that there are 
distinct baseline neurotransmitter levels in several 
brain areas. 
In clinical practice the beneficial effect of 
dopaminergic restoration is very well established, but 
the effect is more complex on non-motor symptoms. 
Some of the consequences might be favourable, for 
example when we consider the dopaminergic effect 
on learning and some affective symptoms. However, 
medicated PD patients are more attracted to posi-
tive outcomes and rewarding stimuli. It is related to 
changes in personality traits such as novelty seeking 
and harm avoidance (Bódi et al., 2009). 
In contrast, the outcome elicited by dopaminergic 
replacement therapy might be less favourable regard-
ing impulsive decision making, attenuated cognitive 
flexibility, and impaired sequence learning. Based 
on electrophysiological studies, neuroimaging tech-
niques, and clinical evidence it can be concluded 
that the traditional view of Parkinson’s disease as 
a circumscribed basal ganglia disorder is changing. 
The main neuropathological hallmark of dopaminer-
gic neural loss also affects the limbic system, including 
the hippocampal formation.
Currently, extensive data on hippocampal dys-
function in PD are less available, but recent trends in 
clinical neuroscience indicate that this new direction 
is promising to better understand the mechanisms 
of behavioural alterations in PD.  
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A Parkinson-kóros betegek vizsgálata célszerűnek bizonyul a módosult dopaminerg neuro-
transzmisszió kognitív jelenségeinek feltérképezésében. A Parkinson-kór a neurodegeneratív 
betegségek közé tartozik, elsősorban a bazális ganglinok érintettek, habár az utóbbi időben 
a nem-motoros tünetek hátterének vizsgálata során jelentős figyelem irányul a hippokampuszra 
is. A betegség neuropatológiai előrehaladását tekintve kezdetben elsősorban a dorzális 
striátum érintett, míg a ventrális striátum struktúrái megtartottak. Az újabb eredmények felvetik 
a hippokampusz korai károsodását is.  Klinikai szempontból  specifikus, enyhe kognitív tünetek 
már a Parkinson-kór korai stádiumában is megjelenhetnek. Elfogadott tény a szubsztitúciós 
kezelés kedvező hatása a motoros tünetekre, de a kognitív tünetek esetében ellentmondásos 
hatásokkal számolhatunk. A betegség neuropatológiai és klinikai jellemzői egy megfelelő 
modellt kínálnak a terápiaként alkalmazott dopmain-pótlás hatásainak vizsgálatára az eltérő 
dopaminszintel rendelkező idegi struktúrák között. Közleményünk célja a bazális ganglionok 
és limbikus rendszer kapcsolatával foglakozó vizsgálatok eredményeinek összegzése a kognitív 
és tanulási mechanizmusok tükrében, különös tekintettel a hippocampusra.
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Viselkedési mintázatok vizsgálata a bazális ganglionok  
és a limbikus rendszer átfedésében
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